|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Lipid Sciences, Inc. (LIPD) Granted Two Fundamental Viral Immunotherapy Patents
8/6/2008 10:16:34 AM
PLEASANTON, CA--(Marketwire - August 06, 2008) - Lipid Sciences, Inc. (NASDAQ: LIPD) announced the issuance of two key patents covering fundamental aspects of the Company's Viral Immunotherapy platform. These two patents, 1) U.S. Patent No. 7,407,662 entitled, "Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content," and 2) U.S. Patent No. 7,407,663, "Modified Immunodeficiency Virus Particles" cover the basic composition of viral particles resulting from Lipid Sciences' proprietary viral delipidation process.
|
|
|
|
|
|
|
|
|
|
|